ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Developing Plan To Replace Research Contracts At Academic Institutions With “Program Grants”

February 22, 1974

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Ohio State Schedules Workshop On CCOP

February 5, 1982

SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis.

April 30, 2004

In Brief: Over Half Of Ovarian Cancer Patients Staged Incorrectly; Senate Gets Funding Resolution

April 12, 1985